c-Myc: Central regulator of autophagy and senescence in cancer
Cancer Letters · 2026-05 · 645 · 218315
DOI: 10.1016/j.canlet.2026.218315 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2026-05. Verfasst von Shuai Ji und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, School of Pharmacy, Xuzhou Medical University, Xuzhou, 221004, China; Department o…. Hauptthemen laut MEDLINE: Autophagy, Cellular Senescence, Proto-Oncogene Proteins c-myc, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 312 Literaturangaben. Gefördert von: National University Health System, Project 333 of Jiangsu Province.
Abstract (Originalsprache)
Among the transcriptional regulators of cell fate, c-Myc is one of the most frequently deregulated oncogenes, exerting pleiotropic effects on cellular metabolism, survival, and stress adaptation. C-Myc occupies a pivotal position at the intersection of autophagy and senescence, two essential, yet paradoxical processes in cancer biology. Autophagy can both suppress tumor formation and support the survival of established tumors. In contrast, senescence acts as a barrier to malignant transformation but can also promote tumor progression through the senescence-associated secretory phenotype. C-Myc modulates both autophagy and senescence in a highly context-dependent manner. It acts as either an inducer or a suppressor depending on cellular state and microenvironmental conditions. This dual regulatory capacity underscores its role as a central hub in cell fate decisions. In this review, we first summarize how c-Myc, autophagy, and senescence contribute to tumor biology. We then highlight the molecular mechanisms through which c-Myc regulates autophagy and senescence. We examine how these interactions influence cancer progression. Finally, we discuss emerging therapeutic strategies and clinical trials targeting the c-Myc-mediated autophagy/senescence axis. We also address future challenges and opportunities for exploiting this network in precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, School of Pharmacy, Xuzhou Medical University, Xuzhou, 221004, China; Department of Pharmacology, Yong Loo Lin School of Medicine, National University o…
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, School of Pharmacy, Xuzhou Medical University, Xuzhou, 221004, China.
- Department of Oncology, Xuzhou Affiliated Hospital of Nanjing University of Chinese Medicine, Xuzhou, 221000, China.
- Department of Clinical Laboratory, Lequn Branch, The First Hospital of Jilin University, Changchun, 130021, China.
- Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117600, Singapore; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Si…
- Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, 66160, USA.
Förderung
- National University Health System
- Project 333 of Jiangsu Province
Zitieren
APA
Ji, S., Sun, T., Zhang, Q., Wu, M., Cao, Y., Gao, R., Wang, L., Nicot, C., & Sethi, G. (2026). c-Myc: Central regulator of autophagy and senescence in cancer. Cancer Letters, 645, 218315. https://doi.org/10.1016/j.canlet.2026.218315
Vancouver
Ji S, Sun T, Zhang Q, Wu M, Cao Y, Gao R, et al. c-Myc: Central regulator of autophagy and senescence in cancer. Cancer Letters. 2026;645:218315. doi:10.1016/j.canlet.2026.218315
BibTeX
@article{Ji2026,
author = {Ji, Shuai and Sun, Ting and Zhang, Qi and Wu, Mingyue and Cao, Yang and Gao, Ran and Wang, Lingzhi and Nicot, Christophe and Sethi, Gautam},
title = {c-Myc: Central regulator of autophagy and senescence in cancer},
journal = {Cancer Letters},
year = {2026},
volume = {645},
pages = {218315},
doi = {10.1016/j.canlet.2026.218315}
}
EUVIMED